Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxc1
|
ENSMUSG00000050295.2 | forkhead box C1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_31807108_31807441 | Foxc1 | 641 | 0.690127 | -0.84 | 6.5e-16 | Click! |
chr13_31811463_31811641 | Foxc1 | 4919 | 0.188163 | -0.81 | 9.9e-14 | Click! |
chr13_31806924_31807104 | Foxc1 | 381 | 0.844798 | -0.79 | 1.1e-12 | Click! |
chr13_31808065_31808335 | Foxc1 | 1567 | 0.355723 | -0.74 | 9.0e-11 | Click! |
chr13_31806171_31806372 | Foxc1 | 362 | 0.855437 | -0.73 | 2.0e-10 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 28.83 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr1_156987024_156987430 | 19.65 |
4930439D14Rik |
RIKEN cDNA 4930439D14 gene |
47389 |
0.1 |
chr11_90727827_90728134 | 18.29 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39614 |
0.15 |
chr13_93388637_93389177 | 15.98 |
Gm47155 |
predicted gene, 47155 |
21876 |
0.14 |
chr19_55938421_55938984 | 15.41 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40393 |
0.17 |
chr4_40849978_40850191 | 15.12 |
Mir5123 |
microRNA 5123 |
54 |
0.54 |
chr12_79674954_79675872 | 14.21 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr16_36062065_36062536 | 13.86 |
Fam162a |
family with sequence similarity 162, member A |
9069 |
0.11 |
chr10_61123250_61123407 | 13.84 |
Gm44308 |
predicted gene, 44308 |
1907 |
0.27 |
chr17_63261844_63262284 | 13.75 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
50907 |
0.13 |
chr2_15164151_15164466 | 13.48 |
Gm13313 |
predicted gene 13313 |
36708 |
0.16 |
chr8_77422723_77422899 | 13.44 |
Gm45407 |
predicted gene 45407 |
50295 |
0.12 |
chr19_24513278_24513483 | 13.22 |
Fam122a |
family with sequence similarity 122, member A |
36024 |
0.14 |
chr11_48873308_48874023 | 13.21 |
Irgm1 |
immunity-related GTPase family M member 1 |
1982 |
0.19 |
chr8_120372799_120373102 | 12.97 |
Gm22715 |
predicted gene, 22715 |
70599 |
0.09 |
chr6_5156932_5157313 | 12.67 |
Pon1 |
paraoxonase 1 |
36641 |
0.14 |
chr19_41495576_41495952 | 12.66 |
Lcor |
ligand dependent nuclear receptor corepressor |
12735 |
0.21 |
chr6_116350044_116350568 | 12.59 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
79 |
0.95 |
chr3_89147017_89147649 | 12.57 |
Hcn3 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 3 |
3881 |
0.08 |
chr13_38632360_38632557 | 12.54 |
Gm47400 |
predicted gene, 47400 |
2513 |
0.19 |
chr5_23850355_23851323 | 12.40 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr11_85339500_85339819 | 12.13 |
Bcas3 |
breast carcinoma amplified sequence 3 |
13508 |
0.19 |
chr6_38924531_38924702 | 12.10 |
Tbxas1 |
thromboxane A synthase 1, platelet |
5592 |
0.22 |
chr6_39429158_39429338 | 12.09 |
Gm25402 |
predicted gene, 25402 |
6829 |
0.14 |
chr7_103824705_103825121 | 12.08 |
Hbb-bs |
hemoglobin, beta adult s chain |
2812 |
0.09 |
chr1_181257261_181257857 | 11.81 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr18_64537841_64538055 | 11.64 |
Atp8b1 |
ATPase, class I, type 8B, member 1 |
17252 |
0.15 |
chr15_9472966_9473152 | 11.64 |
Gm50456 |
predicted gene, 50456 |
2443 |
0.31 |
chr18_56897999_56898193 | 11.62 |
Gm18087 |
predicted gene, 18087 |
17992 |
0.19 |
chr15_35490089_35490249 | 11.57 |
Gm24771 |
predicted gene, 24771 |
2769 |
0.32 |
chr5_143561547_143562201 | 11.32 |
Fam220a |
family with sequence similarity 220, member A |
12834 |
0.14 |
chr13_17028260_17028429 | 11.03 |
Gm27043 |
predicted gene, 27043 |
22577 |
0.23 |
chr11_62605415_62606716 | 10.81 |
Lrrc75aos2 |
leucine rich repeat containing 75A, opposite strand 2 |
298 |
0.72 |
chr6_90333135_90333323 | 10.74 |
Uroc1 |
urocanase domain containing 1 |
55 |
0.95 |
chr18_84389765_84390095 | 10.61 |
Gm37216 |
predicted gene, 37216 |
13784 |
0.22 |
chr11_69919627_69920112 | 10.61 |
Eif5a |
eukaryotic translation initiation factor 5A |
761 |
0.32 |
chr4_72200825_72201688 | 10.48 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
92 |
0.8 |
chr11_46078060_46078305 | 10.37 |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
22124 |
0.11 |
chr19_40769316_40769607 | 10.37 |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
4909 |
0.21 |
chr13_118629682_118629962 | 10.29 |
Gm10732 |
predicted gene 10732 |
28921 |
0.13 |
chr3_157636891_157637254 | 10.17 |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
70172 |
0.09 |
chr3_121291927_121292619 | 10.14 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr12_83910386_83910537 | 10.10 |
Numb |
NUMB endocytic adaptor protein |
11272 |
0.12 |
chr11_19924323_19926342 | 9.99 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr10_13202020_13202182 | 9.97 |
Gm47402 |
predicted gene, 47402 |
3125 |
0.24 |
chr1_152817059_152817770 | 9.80 |
Ncf2 |
neutrophil cytosolic factor 2 |
6155 |
0.16 |
chr8_68275265_68275750 | 9.63 |
Sh2d4a |
SH2 domain containing 4A |
1060 |
0.53 |
chr1_88267467_88268681 | 9.63 |
Hjurp |
Holliday junction recognition protein |
1318 |
0.28 |
chr6_108529607_108529783 | 9.62 |
Gm44040 |
predicted gene, 44040 |
4008 |
0.18 |
chr4_134869893_134870066 | 9.61 |
Rhd |
Rh blood group, D antigen |
5443 |
0.18 |
chr15_67176391_67177544 | 9.56 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
137 |
0.97 |
chr1_175082553_175082856 | 9.56 |
Rgs7 |
regulator of G protein signaling 7 |
3279 |
0.38 |
chr15_103256585_103256800 | 9.44 |
Nfe2 |
nuclear factor, erythroid derived 2 |
1253 |
0.29 |
chr13_74735599_74735790 | 9.42 |
Cast |
calpastatin |
1352 |
0.45 |
chr1_131125857_131126184 | 9.38 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
12225 |
0.13 |
chr4_119028467_119028820 | 9.32 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr3_41169534_41169725 | 9.30 |
Gm40038 |
predicted gene, 40038 |
3034 |
0.31 |
chr6_31586330_31586508 | 9.30 |
Gm6117 |
predicted gene 6117 |
11452 |
0.17 |
chr14_31045396_31045562 | 9.23 |
Gm49094 |
predicted gene, 49094 |
2359 |
0.15 |
chr6_146611446_146611715 | 9.23 |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
22918 |
0.11 |
chr6_28232245_28232573 | 9.15 |
Gm42548 |
predicted gene 42548 |
4604 |
0.16 |
chr13_59738233_59738419 | 9.12 |
1700014D04Rik |
RIKEN cDNA 1700014D04 gene |
4424 |
0.09 |
chr2_174329445_174331091 | 9.10 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr2_79259164_79259332 | 9.10 |
Itga4 |
integrin alpha 4 |
3301 |
0.3 |
chr5_50126295_50126569 | 9.08 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
24901 |
0.19 |
chr2_30417882_30418061 | 9.01 |
Ptpa |
protein phosphatase 2 protein activator |
1669 |
0.2 |
chr10_128665371_128665522 | 8.99 |
Ikzf4 |
IKAROS family zinc finger 4 |
3912 |
0.09 |
chr18_42262448_42262930 | 8.99 |
Lars |
leucyl-tRNA synthetase |
495 |
0.7 |
chr13_109683095_109683266 | 8.98 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
2976 |
0.42 |
chr10_120216764_120217346 | 8.87 |
Tmbim4 |
transmembrane BAX inhibitor motif containing 4 |
3633 |
0.18 |
chr4_45341633_45342861 | 8.82 |
Dcaf10 |
DDB1 and CUL4 associated factor 10 |
65 |
0.87 |
chr4_40850264_40850447 | 8.80 |
Gm25931 |
predicted gene, 25931 |
47 |
0.49 |
chr9_50922918_50923071 | 8.74 |
Gm25558 |
predicted gene, 25558 |
35044 |
0.13 |
chr15_9079113_9079323 | 8.66 |
Nadk2 |
NAD kinase 2, mitochondrial |
3941 |
0.26 |
chr10_40132122_40132315 | 8.66 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
10036 |
0.14 |
chr4_109256140_109256309 | 8.65 |
Calr4 |
calreticulin 4 |
11642 |
0.19 |
chr5_73355501_73355893 | 8.62 |
Ociad2 |
OCIA domain containing 2 |
14669 |
0.11 |
chr3_37553360_37553534 | 8.58 |
Gm12564 |
predicted gene 12564 |
3056 |
0.19 |
chr16_36891556_36891720 | 8.58 |
Gm49600 |
predicted gene, 49600 |
2756 |
0.14 |
chr11_79054816_79055084 | 8.58 |
Ksr1 |
kinase suppressor of ras 1 |
2677 |
0.28 |
chr9_123846579_123846755 | 8.57 |
Fyco1 |
FYVE and coiled-coil domain containing 1 |
2061 |
0.23 |
chr18_24202471_24202631 | 8.49 |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
2793 |
0.31 |
chr1_130731762_130732102 | 8.48 |
AA986860 |
expressed sequence AA986860 |
44 |
0.94 |
chr6_55324727_55325118 | 8.47 |
Aqp1 |
aquaporin 1 |
11510 |
0.14 |
chr18_81902584_81902818 | 8.46 |
Gm50292 |
predicted gene, 50292 |
14027 |
0.17 |
chr9_50811130_50811331 | 8.41 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
2551 |
0.2 |
chr2_6263938_6264314 | 8.39 |
Gm13383 |
predicted gene 13383 |
6860 |
0.19 |
chr19_44394817_44395182 | 8.32 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
11691 |
0.14 |
chr7_90062841_90063193 | 8.28 |
Gm44861 |
predicted gene 44861 |
20320 |
0.11 |
chr9_101995790_101996096 | 8.24 |
Gm31326 |
predicted gene, 31326 |
6683 |
0.2 |
chr1_24613351_24614205 | 8.24 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr4_150518987_150519148 | 8.23 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
30674 |
0.18 |
chr1_185471753_185471924 | 8.19 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
15456 |
0.12 |
chr11_105836524_105836687 | 8.19 |
Gm11653 |
predicted gene 11653 |
39300 |
0.13 |
chr17_71204102_71204303 | 8.12 |
Lpin2 |
lipin 2 |
452 |
0.8 |
chr1_174169231_174169382 | 8.10 |
Gm43440 |
predicted gene 43440 |
1604 |
0.21 |
chr2_62619174_62619348 | 8.09 |
Ifih1 |
interferon induced with helicase C domain 1 |
20212 |
0.17 |
chr6_58642386_58642566 | 8.09 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
1894 |
0.39 |
chr14_66999353_66999533 | 8.07 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
214 |
0.92 |
chr10_12962337_12962498 | 8.07 |
Stx11 |
syntaxin 11 |
1841 |
0.35 |
chr17_29444007_29444198 | 8.07 |
Gm36199 |
predicted gene, 36199 |
1803 |
0.23 |
chr9_110859283_110859465 | 8.03 |
Prss50 |
protease, serine 50 |
1407 |
0.22 |
chr15_77973920_77974210 | 8.01 |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
3252 |
0.19 |
chr5_36685319_36685475 | 8.01 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
10540 |
0.13 |
chr11_109555645_109556032 | 8.00 |
Arsg |
arylsulfatase G |
12084 |
0.16 |
chr9_111057150_111057866 | 8.00 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
11 |
0.95 |
chr3_103129479_103129637 | 7.99 |
Dennd2c |
DENN/MADD domain containing 2C |
2002 |
0.23 |
chr6_127321540_127321865 | 7.99 |
Gm43636 |
predicted gene 43636 |
3361 |
0.16 |
chr13_107063669_107063832 | 7.94 |
Gm31452 |
predicted gene, 31452 |
55 |
0.97 |
chr1_184645271_184645605 | 7.92 |
Gm37800 |
predicted gene, 37800 |
15965 |
0.15 |
chr5_150641496_150641791 | 7.90 |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
5876 |
0.12 |
chr9_72409226_72409810 | 7.90 |
Gm27255 |
predicted gene 27255 |
250 |
0.55 |
chr17_46160104_46160711 | 7.88 |
Gtpbp2 |
GTP binding protein 2 |
625 |
0.56 |
chr12_76941642_76941893 | 7.88 |
Gm47218 |
predicted gene, 47218 |
26 |
0.97 |
chr13_91540451_91540746 | 7.82 |
Ssbp2 |
single-stranded DNA binding protein 2 |
1255 |
0.59 |
chr11_109517832_109518132 | 7.82 |
Gm22378 |
predicted gene, 22378 |
18158 |
0.13 |
chr17_84776723_84776893 | 7.82 |
Lrpprc |
leucine-rich PPR-motif containing |
735 |
0.64 |
chr2_172291094_172291277 | 7.82 |
Gm14275 |
predicted gene 14275 |
3052 |
0.21 |
chr4_151962781_151963059 | 7.74 |
Dnajc11 |
DnaJ heat shock protein family (Hsp40) member C11 |
4918 |
0.14 |
chr4_148203640_148203804 | 7.73 |
Fbxo2 |
F-box protein 2 |
43101 |
0.08 |
chr1_165396068_165396234 | 7.72 |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
7390 |
0.14 |
chr1_59894146_59894414 | 7.68 |
Gm37977 |
predicted gene, 37977 |
6591 |
0.15 |
chr9_64792478_64792650 | 7.68 |
Dennd4a |
DENN/MADD domain containing 4A |
18776 |
0.18 |
chr17_79969002_79969199 | 7.68 |
Gm41625 |
predicted gene, 41625 |
12562 |
0.16 |
chr4_40849590_40849862 | 7.67 |
Mir5123 |
microRNA 5123 |
412 |
0.42 |
chr6_120619174_120619360 | 7.67 |
Gm44124 |
predicted gene, 44124 |
39091 |
0.11 |
chr11_44512747_44512998 | 7.67 |
Rnf145 |
ring finger protein 145 |
6092 |
0.18 |
chr13_93381331_93381617 | 7.66 |
Gm47155 |
predicted gene, 47155 |
29309 |
0.13 |
chr13_101612375_101612655 | 7.66 |
Gm29341 |
predicted gene 29341 |
6282 |
0.22 |
chr17_57228051_57228489 | 7.65 |
C3 |
complement component 3 |
134 |
0.93 |
chr19_34517301_34517475 | 7.64 |
Lipa |
lysosomal acid lipase A |
6408 |
0.14 |
chr7_90145091_90145280 | 7.62 |
Gm45222 |
predicted gene 45222 |
763 |
0.51 |
chr2_28616496_28616661 | 7.61 |
Gfi1b |
growth factor independent 1B |
1173 |
0.33 |
chr13_75738685_75738841 | 7.61 |
Ell2 |
elongation factor RNA polymerase II 2 |
7588 |
0.13 |
chr13_59796221_59796392 | 7.59 |
Tut7 |
terminal uridylyl transferase 7 |
824 |
0.42 |
chr10_75697353_75697856 | 7.56 |
Cabin1 |
calcineurin binding protein 1 |
2771 |
0.19 |
chr3_89880567_89880728 | 7.55 |
Gm42809 |
predicted gene 42809 |
32269 |
0.09 |
chr14_79300760_79302137 | 7.52 |
Rgcc |
regulator of cell cycle |
197 |
0.94 |
chr15_9114613_9115328 | 7.47 |
Nadk2 |
NAD kinase 2, mitochondrial |
11982 |
0.18 |
chr7_25279370_25280622 | 7.45 |
Cic |
capicua transcriptional repressor |
355 |
0.74 |
chr17_21473484_21473684 | 7.43 |
Zfp53 |
zinc finger protein 53 |
15414 |
0.1 |
chr17_12037128_12037442 | 7.40 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
7369 |
0.28 |
chr8_123978851_123979300 | 7.40 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4047 |
0.12 |
chr7_109636438_109636727 | 7.39 |
Denn2b |
DENN domain containing 2B |
19435 |
0.15 |
chr13_59738423_59738823 | 7.36 |
1700014D04Rik |
RIKEN cDNA 1700014D04 gene |
4127 |
0.09 |
chr1_184814156_184814307 | 7.28 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
2918 |
0.2 |
chr9_65529728_65529893 | 7.26 |
Gm17749 |
predicted gene, 17749 |
4 |
0.97 |
chr14_47527928_47528092 | 7.25 |
Fbxo34 |
F-box protein 34 |
1931 |
0.23 |
chr13_74071260_74071584 | 7.25 |
Cep72 |
centrosomal protein 72 |
9123 |
0.15 |
chr13_14033794_14033945 | 7.24 |
Tbce |
tubulin-specific chaperone E |
5710 |
0.13 |
chr18_32542832_32543024 | 7.23 |
Gypc |
glycophorin C |
7510 |
0.2 |
chr2_34783047_34783388 | 7.23 |
Hspa5 |
heat shock protein 5 |
8370 |
0.12 |
chr10_127512528_127514054 | 7.20 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
1676 |
0.21 |
chr9_64953225_64953560 | 7.18 |
Slc24a1 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 |
1785 |
0.27 |
chr11_49083788_49084231 | 7.17 |
Ifi47 |
interferon gamma inducible protein 47 |
2691 |
0.13 |
chr12_112829543_112830189 | 7.17 |
Cdca4 |
cell division cycle associated 4 |
443 |
0.7 |
chr5_91721429_91721748 | 7.17 |
Trmt112-ps1 |
tRNA methyltransferase 11-2, pseudogene 1 |
16491 |
0.15 |
chr11_51739109_51739278 | 7.16 |
Gm25291 |
predicted gene, 25291 |
1271 |
0.38 |
chr11_31001805_31001958 | 7.15 |
Gm12102 |
predicted gene 12102 |
2017 |
0.29 |
chr8_109586960_109587627 | 7.15 |
Dhodh |
dihydroorotate dehydrogenase |
6758 |
0.14 |
chr2_163692169_163692458 | 7.13 |
Gm16316 |
predicted gene 16316 |
34 |
0.96 |
chr5_147888610_147888912 | 7.11 |
Slc46a3 |
solute carrier family 46, member 3 |
6054 |
0.17 |
chr10_127508848_127510720 | 7.11 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr7_103861338_103861749 | 7.10 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
8327 |
0.06 |
chr3_60820114_60820323 | 7.09 |
Gm38326 |
predicted gene, 38326 |
31857 |
0.15 |
chr1_161895111_161895271 | 7.09 |
Gm31925 |
predicted gene, 31925 |
3044 |
0.21 |
chr1_82373706_82374341 | 7.06 |
Gm19552 |
predicted gene, 19552 |
21806 |
0.14 |
chr6_67161663_67162061 | 7.06 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chrX_142680720_142682167 | 7.06 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr10_40125174_40125635 | 7.05 |
Gm25613 |
predicted gene, 25613 |
15942 |
0.13 |
chr11_32298735_32298903 | 7.03 |
Hbq1a |
hemoglobin, theta 1A |
1250 |
0.28 |
chr1_166812014_166812333 | 7.01 |
Gm37904 |
predicted gene, 37904 |
13334 |
0.22 |
chr11_44513167_44513330 | 7.01 |
Rnf145 |
ring finger protein 145 |
5716 |
0.18 |
chr5_148716758_148716935 | 7.00 |
Gm36186 |
predicted gene, 36186 |
5380 |
0.18 |
chr16_92825453_92825611 | 6.95 |
Runx1 |
runt related transcription factor 1 |
246 |
0.95 |
chr9_40806234_40806672 | 6.93 |
Snord14e |
small nucleolar RNA, C/D box 14E |
1705 |
0.17 |
chr8_20379727_20380988 | 6.93 |
Gm7807 |
predicted gene 7807 |
724 |
0.67 |
chr19_32239325_32239637 | 6.92 |
Sgms1 |
sphingomyelin synthase 1 |
655 |
0.76 |
chr8_46363237_46363388 | 6.89 |
Gm30931 |
predicted gene, 30931 |
56 |
0.96 |
chr14_67000360_67000524 | 6.88 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
66 |
0.97 |
chr7_7298676_7299288 | 6.88 |
Mir5620 |
microRNA 5620 |
91 |
0.61 |
chr13_23683510_23684675 | 6.88 |
H2bc4 |
H2B clustered histone 4 |
107 |
0.49 |
chr10_94931912_94932258 | 6.87 |
Plxnc1 |
plexin C1 |
9428 |
0.21 |
chr7_135816259_135816526 | 6.85 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
37290 |
0.12 |
chr4_32987000_32987211 | 6.85 |
Rragd |
Ras-related GTP binding D |
3651 |
0.16 |
chr2_79259353_79259890 | 6.84 |
Itga4 |
integrin alpha 4 |
3674 |
0.29 |
chr8_107292888_107294249 | 6.82 |
Nfat5 |
nuclear factor of activated T cells 5 |
9 |
0.98 |
chr5_36620484_36620644 | 6.79 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
691 |
0.54 |
chr13_38632632_38632987 | 6.76 |
Gm47400 |
predicted gene, 47400 |
2162 |
0.21 |
chr5_149635760_149636523 | 6.76 |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
30 |
0.97 |
chr5_137085033_137085367 | 6.73 |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
12932 |
0.11 |
chr13_95688563_95688884 | 6.73 |
Gm48745 |
predicted gene, 48745 |
3578 |
0.17 |
chr1_90275840_90276031 | 6.71 |
Gm28723 |
predicted gene 28723 |
4523 |
0.2 |
chr13_19178014_19178322 | 6.71 |
Gm31887 |
predicted gene, 31887 |
15390 |
0.21 |
chr15_83593753_83593930 | 6.70 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
1316 |
0.35 |
chr17_79926491_79926764 | 6.70 |
Gm6552 |
predicted gene 6552 |
7945 |
0.18 |
chr5_146250723_146251020 | 6.69 |
Gm15739 |
predicted gene 15739 |
2320 |
0.2 |
chr12_4872752_4872922 | 6.69 |
Mfsd2b |
major facilitator superfamily domain containing 2B |
1508 |
0.28 |
chr12_4679914_4680233 | 6.69 |
Gm17541 |
predicted gene, 17541 |
9853 |
0.12 |
chr11_32250921_32251298 | 6.67 |
Nprl3 |
nitrogen permease regulator-like 3 |
831 |
0.45 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.6 | 13.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
4.3 | 12.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
4.0 | 4.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.8 | 15.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
3.5 | 17.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.5 | 3.5 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.5 | 20.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.4 | 10.2 | GO:0032782 | bile acid secretion(GO:0032782) |
3.3 | 13.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.2 | 9.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.1 | 12.4 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
3.0 | 18.2 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
3.0 | 9.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.0 | 12.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
3.0 | 6.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.0 | 12.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.0 | 14.9 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
2.9 | 5.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.9 | 11.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.9 | 14.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.9 | 8.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.9 | 8.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.9 | 2.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
2.8 | 11.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.8 | 13.9 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.8 | 11.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.8 | 13.9 | GO:0070627 | ferrous iron import(GO:0070627) |
2.8 | 8.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.8 | 11.0 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.8 | 8.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.7 | 13.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.7 | 10.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.7 | 8.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.6 | 10.6 | GO:0050904 | diapedesis(GO:0050904) |
2.6 | 10.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
2.6 | 10.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.6 | 2.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.5 | 10.1 | GO:0070836 | caveola assembly(GO:0070836) |
2.5 | 10.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.5 | 7.4 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.4 | 14.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
2.4 | 2.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.4 | 7.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
2.4 | 7.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.4 | 14.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.3 | 9.4 | GO:0009597 | detection of virus(GO:0009597) |
2.3 | 7.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.3 | 9.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.3 | 4.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.3 | 11.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.3 | 13.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.3 | 15.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
2.2 | 6.6 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.2 | 8.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.2 | 8.7 | GO:0008228 | opsonization(GO:0008228) |
2.2 | 4.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.2 | 6.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.2 | 6.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.1 | 2.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.1 | 6.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.1 | 10.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
2.1 | 6.3 | GO:0000087 | mitotic M phase(GO:0000087) |
2.1 | 8.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.1 | 53.5 | GO:0048821 | erythrocyte development(GO:0048821) |
2.0 | 6.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.0 | 12.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.0 | 5.9 | GO:0001555 | oocyte growth(GO:0001555) |
2.0 | 15.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.0 | 7.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.9 | 5.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.9 | 7.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.9 | 3.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.9 | 5.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.9 | 7.7 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.9 | 3.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.9 | 3.8 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.9 | 9.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.9 | 9.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.9 | 9.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.9 | 7.4 | GO:0032264 | IMP salvage(GO:0032264) |
1.8 | 7.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.8 | 11.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.8 | 9.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.8 | 7.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.8 | 9.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.8 | 7.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.8 | 10.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.8 | 5.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.8 | 1.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.8 | 5.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.8 | 5.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.8 | 5.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.8 | 5.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.8 | 3.5 | GO:0045472 | response to ether(GO:0045472) |
1.8 | 10.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.7 | 1.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.7 | 5.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.7 | 6.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.7 | 5.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.7 | 25.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.7 | 5.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.7 | 5.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.7 | 1.7 | GO:1901656 | glycoside transport(GO:1901656) |
1.7 | 6.8 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.7 | 8.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.7 | 6.8 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.7 | 5.1 | GO:0018343 | protein farnesylation(GO:0018343) |
1.7 | 3.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.7 | 30.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.7 | 36.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.6 | 11.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.6 | 1.6 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.6 | 6.5 | GO:0015793 | glycerol transport(GO:0015793) |
1.6 | 3.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.6 | 6.4 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.6 | 4.8 | GO:0070268 | cornification(GO:0070268) |
1.6 | 1.6 | GO:0070723 | response to cholesterol(GO:0070723) |
1.6 | 4.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.6 | 3.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.6 | 4.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.6 | 12.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.6 | 1.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.6 | 1.6 | GO:0070384 | Harderian gland development(GO:0070384) |
1.5 | 7.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.5 | 4.6 | GO:1903416 | response to glycoside(GO:1903416) |
1.5 | 6.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.5 | 4.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.5 | 4.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.5 | 7.5 | GO:0051601 | exocyst localization(GO:0051601) |
1.5 | 9.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.5 | 3.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.5 | 10.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.5 | 6.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.5 | 5.9 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.5 | 1.5 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.5 | 1.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.5 | 16.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.5 | 4.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.5 | 1.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.5 | 4.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.4 | 4.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.4 | 4.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 10.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.4 | 12.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.4 | 7.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.4 | 4.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.4 | 4.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.4 | 4.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.4 | 7.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.4 | 5.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.4 | 5.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.4 | 4.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.4 | 8.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.4 | 4.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.4 | 4.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.4 | 2.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.4 | 8.1 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.3 | 5.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.3 | 1.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
1.3 | 8.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.3 | 4.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.3 | 6.6 | GO:1901563 | response to camptothecin(GO:1901563) |
1.3 | 2.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 2.6 | GO:0002254 | kinin cascade(GO:0002254) |
1.3 | 2.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.3 | 3.9 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
1.3 | 3.9 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.3 | 5.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.3 | 3.9 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.3 | 2.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
1.3 | 3.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.3 | 3.9 | GO:0007525 | somatic muscle development(GO:0007525) |
1.3 | 12.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.3 | 6.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.3 | 3.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.3 | 2.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.3 | 5.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.3 | 2.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.3 | 1.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.3 | 2.5 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
1.2 | 6.2 | GO:0080009 | mRNA methylation(GO:0080009) |
1.2 | 13.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.2 | 3.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.2 | 3.7 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.2 | 6.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.2 | 4.9 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 6.1 | GO:0015671 | oxygen transport(GO:0015671) |
1.2 | 13.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.2 | 28.1 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
1.2 | 4.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.2 | 8.5 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.2 | 2.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.2 | 10.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.2 | 2.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.2 | 15.7 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.2 | 6.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.2 | 4.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.2 | 3.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.2 | 3.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.2 | 4.8 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.2 | 3.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.2 | 5.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 5.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.2 | 2.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 3.5 | GO:0032439 | endosome localization(GO:0032439) |
1.2 | 2.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.2 | 4.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.2 | 10.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.1 | 3.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.1 | 4.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.1 | 10.3 | GO:0042730 | fibrinolysis(GO:0042730) |
1.1 | 2.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) nucleoside salvage(GO:0043174) |
1.1 | 1.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.1 | 3.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.1 | 5.7 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.1 | 1.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.1 | 5.7 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.1 | 3.4 | GO:0019532 | oxalate transport(GO:0019532) |
1.1 | 3.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.1 | 2.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.1 | 2.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.1 | 2.3 | GO:0042117 | monocyte activation(GO:0042117) |
1.1 | 9.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.1 | 3.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.1 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.1 | 3.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.1 | 5.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 4.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 1.1 | GO:0036394 | amylase secretion(GO:0036394) |
1.1 | 9.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.1 | 4.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.1 | 3.3 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
1.1 | 4.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.1 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.1 | 2.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.1 | 19.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 1.1 | GO:1901164 | regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
1.1 | 1.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.1 | 5.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
1.1 | 2.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.1 | 1.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
1.1 | 1.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.1 | 4.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.1 | 5.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.1 | 4.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.1 | 3.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 2.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.1 | 3.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.1 | 1.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
1.1 | 4.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.1 | 6.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.1 | 3.2 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 2.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.0 | 3.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 2.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 3.1 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 1.0 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
1.0 | 8.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.0 | 3.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.0 | 2.1 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.0 | 2.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.0 | 1.0 | GO:0035799 | ureter maturation(GO:0035799) |
1.0 | 3.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
1.0 | 17.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.0 | 8.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.0 | 3.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.0 | 3.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.0 | 3.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.0 | 1.0 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.0 | 3.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.0 | 4.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.0 | 3.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.0 | 5.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 3.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.0 | 2.0 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.0 | 4.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.0 | 2.0 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.0 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.0 | 1.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.0 | 10.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.0 | 4.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.0 | 1.0 | GO:0018904 | ether metabolic process(GO:0018904) |
1.0 | 2.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.0 | 2.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.0 | 3.9 | GO:0006563 | L-serine metabolic process(GO:0006563) |
1.0 | 2.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 2.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.0 | 1.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.0 | 2.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
1.0 | 9.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.0 | 2.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.0 | 15.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.0 | 1.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.0 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.0 | 4.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.0 | 6.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.9 | 3.8 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.9 | 8.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.9 | 1.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.9 | 3.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.9 | 0.9 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.9 | 4.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.9 | 0.9 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.9 | 3.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 11.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 0.9 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 1.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.9 | 2.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 5.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.9 | 2.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.9 | 5.5 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.9 | 2.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 10.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.9 | 2.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.9 | 0.9 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.9 | 2.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.9 | 4.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.9 | 1.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.9 | 4.5 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.9 | 4.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.9 | 2.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.9 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 1.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.9 | 3.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.9 | 3.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 2.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 4.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.9 | 2.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.9 | 10.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.9 | 1.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.9 | 12.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.9 | 1.7 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.9 | 6.9 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.9 | 5.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.9 | 3.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 3.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.9 | 4.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.9 | 2.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.9 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 0.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.8 | 4.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.8 | 3.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.8 | 3.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.8 | 7.6 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.8 | 3.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 0.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.8 | 1.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.8 | 3.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.8 | 5.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.8 | 8.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.8 | 1.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.8 | 2.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.8 | 4.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.8 | 2.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.8 | 5.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.8 | 3.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 2.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.8 | 0.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.8 | 1.6 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.8 | 2.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.8 | 0.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.8 | 0.8 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 1.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.8 | 2.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.8 | 1.6 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.8 | 4.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.8 | 6.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.8 | 2.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.8 | 7.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.8 | 1.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 5.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.8 | 6.5 | GO:0046697 | decidualization(GO:0046697) |
0.8 | 2.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.8 | 0.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.8 | 4.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 18.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.8 | 6.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.8 | 4.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.8 | 1.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.8 | 4.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.8 | 3.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.8 | 8.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.8 | 4.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 2.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.8 | 0.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.8 | 12.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 0.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.8 | 1.6 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.8 | 11.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 0.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.8 | 3.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.8 | 2.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 2.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.8 | 1.6 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.8 | 3.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.8 | 1.5 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.8 | 3.1 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.8 | 5.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.8 | 2.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 3.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.8 | 0.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 2.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.8 | 3.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.8 | 1.5 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.8 | 5.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.8 | 1.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.8 | 5.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 9.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.8 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.8 | 8.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.8 | 3.8 | GO:0015871 | choline transport(GO:0015871) |
0.8 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.7 | 2.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 1.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.7 | 2.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.7 | 7.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.7 | 0.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.7 | 8.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.7 | 5.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.7 | 9.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 0.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.7 | 1.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 2.2 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.7 | 2.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 4.4 | GO:0042168 | heme metabolic process(GO:0042168) |
0.7 | 6.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.7 | 2.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.7 | 0.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.7 | 1.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.7 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 2.9 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.7 | 17.4 | GO:0006414 | translational elongation(GO:0006414) |
0.7 | 0.7 | GO:0042368 | negative regulation of vitamin D biosynthetic process(GO:0010957) vitamin D biosynthetic process(GO:0042368) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) |
0.7 | 15.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.7 | 0.7 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.7 | 1.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 6.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.7 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 2.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.7 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 2.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 1.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 2.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.7 | 3.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 4.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.7 | 1.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.7 | 3.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 0.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.7 | 3.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.7 | 2.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.7 | 29.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.7 | 3.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 1.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.7 | 2.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 2.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.7 | 2.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.7 | 1.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.7 | 2.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 2.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.7 | 2.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.7 | 2.8 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.7 | 4.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 6.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.7 | 1.4 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.7 | 10.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.7 | 0.7 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.7 | 1.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 8.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.7 | 6.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 1.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.7 | 0.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 1.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 4.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.7 | 2.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 4.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 2.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.7 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.7 | 1.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 2.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.7 | 2.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.7 | 2.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.7 | 2.7 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.7 | 13.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.7 | 6.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.7 | 1.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.7 | 0.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.7 | 5.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 1.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.7 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 2.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.7 | 3.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.7 | 4.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 2.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.7 | 2.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.7 | 2.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.7 | 0.7 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.7 | 0.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 0.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.7 | 6.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.7 | 3.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.7 | 5.2 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.7 | 9.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.7 | 3.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.7 | 3.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 2.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 7.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.6 | 1.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 1.9 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.6 | 0.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.6 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.6 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 4.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.6 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 3.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 8.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 1.9 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.6 | 2.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 2.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.6 | 8.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 1.3 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 1.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 3.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 0.6 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.6 | 3.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 3.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.6 | 4.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.6 | 1.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 4.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 5.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.6 | 2.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 8.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.6 | 1.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.6 | 10.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 1.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 1.2 | GO:0050955 | thermoception(GO:0050955) |
0.6 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 4.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.6 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 1.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 2.5 | GO:0001562 | response to protozoan(GO:0001562) |
0.6 | 0.6 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.6 | 3.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.6 | 1.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 3.7 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.6 | 4.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.6 | 1.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 20.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.6 | 1.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 3.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.6 | 3.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 1.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 3.0 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.6 | 17.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.6 | 0.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.6 | 6.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.6 | 7.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.6 | 0.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.6 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 1.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.6 | 1.2 | GO:0030421 | defecation(GO:0030421) |
0.6 | 1.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 2.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 1.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 0.6 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.6 | 4.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 3.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.6 | 1.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 3.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.6 | 1.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.6 | 2.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 4.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.6 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.6 | 1.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 8.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.6 | 0.6 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 3.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 2.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 1.7 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 3.5 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 0.6 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.6 | 2.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.6 | 4.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.6 | 0.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.6 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 1.7 | GO:0009838 | abscission(GO:0009838) |
0.6 | 3.4 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.6 | 2.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.6 | 0.6 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.6 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.6 | 2.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 4.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.6 | 4.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 5.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.6 | 10.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.6 | 1.1 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.6 | 4.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.6 | 1.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 4.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.6 | 12.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.6 | 0.6 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.6 | 1.1 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.6 | 0.6 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.6 | 7.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.6 | 1.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.6 | 3.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 0.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 0.6 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 5.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.6 | 1.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.6 | 2.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 1.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 3.8 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.5 | 2.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 1.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.5 | 1.6 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 2.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 11.9 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.5 | 1.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 5.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 2.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 1.6 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.5 | 1.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 3.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 3.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.5 | 7.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.5 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 3.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 0.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.5 | 2.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 2.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.5 | 1.1 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.5 | 8.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.5 | 2.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 7.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 3.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 1.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.5 | 2.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.5 | 6.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 2.7 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.5 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 1.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 1.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 6.3 | GO:0051168 | nuclear export(GO:0051168) |
0.5 | 3.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 0.5 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
0.5 | 1.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 0.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 3.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 2.6 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.5 | 2.6 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.5 | 1.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 0.5 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.5 | 2.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 1.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.5 | 3.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.5 | 2.6 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 5.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.5 | 3.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 1.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 3.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 2.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.5 | 11.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.5 | 1.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.5 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 13.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 0.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 9.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.5 | 2.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.5 | 2.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 1.0 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 2.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.5 | 1.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 5.0 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.5 | 1.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 0.5 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.5 | 2.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 1.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.5 | 1.5 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.5 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 2.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.5 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 1.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 2.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.5 | 0.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.5 | 1.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 0.5 | GO:0061724 | lipophagy(GO:0061724) |
0.5 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 2.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.5 | 2.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 1.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 0.5 | GO:0002192 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
0.5 | 1.5 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.5 | 1.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 1.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.5 | 1.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 2.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.5 | 3.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 0.5 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.5 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 1.4 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 1.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 0.5 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.5 | 0.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 0.9 | GO:0019230 | proprioception(GO:0019230) |
0.5 | 6.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 1.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 0.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.5 | 0.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 4.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 1.4 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.5 | 2.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 0.5 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.5 | 2.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 3.2 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.5 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 3.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.5 | 1.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 1.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.5 | 1.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 3.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 2.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 2.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.5 | 4.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 1.8 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.5 | 0.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 0.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 2.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 0.5 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.5 | 2.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.5 | 5.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 0.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 0.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 4.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.4 | 3.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 4.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 3.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.4 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 2.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 0.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 4.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 0.4 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.4 | 0.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 0.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.4 | 0.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 3.5 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.4 | 0.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 0.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 1.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 3.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 0.9 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 12.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 0.9 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 2.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 1.7 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 1.7 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 1.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 0.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.4 | 1.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 0.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 6.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.4 | 1.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 14.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 1.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 1.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.4 | 0.8 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 1.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 1.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.4 | 0.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.4 | 1.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 2.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.4 | 2.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 2.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.4 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.4 | 2.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.4 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 2.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.4 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 9.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.4 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 3.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 1.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 1.6 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.4 | 14.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.4 | 1.6 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.4 | 2.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 2.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 1.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 1.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 0.8 | GO:0070254 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.4 | 1.6 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.4 | 0.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.4 | 2.4 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 2.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 4.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.4 | 5.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.4 | 0.8 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 3.5 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.4 | 0.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 1.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 1.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.4 | 1.2 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 14.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 0.8 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.4 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 5.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.4 | 1.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.4 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 0.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 5.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.4 | 0.4 | GO:2001170 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 1.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 4.2 | GO:0070542 | response to fatty acid(GO:0070542) |
0.4 | 1.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 1.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 0.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 0.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.4 | 4.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 1.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.4 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.4 | 7.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.4 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.4 | 0.4 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.4 | 0.8 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.4 | 2.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 2.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.7 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.4 | 0.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.4 | 2.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.4 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 1.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 1.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 1.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.4 | 2.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 1.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 1.5 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.4 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 0.7 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.4 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 2.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 5.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 1.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 0.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.4 | 0.4 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 1.8 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.4 | 2.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 1.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 4.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 1.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.4 | 0.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.4 | 0.4 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.4 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 2.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 0.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 6.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.3 | 8.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 1.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 3.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 5.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.3 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.3 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 4.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 4.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.3 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.3 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 1.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.7 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.3 | 0.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 1.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 2.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 1.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.3 | 0.7 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.3 | 3.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 12.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 2.7 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.3 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.3 | 1.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 3.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.3 | 1.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 7.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 3.6 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 2.0 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.3 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 0.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 0.3 | GO:1903596 | receptor-mediated virion attachment to host cell(GO:0046813) regulation of gap junction assembly(GO:1903596) |
0.3 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 4.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 1.3 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.3 | 0.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.3 | 1.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 8.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.6 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.3 | 1.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.6 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 1.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 1.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 2.8 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 2.5 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.3 | 5.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 1.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 0.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 6.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 0.3 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.3 | 1.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 1.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.5 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.3 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.9 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 2.1 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 1.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 0.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 2.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 1.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 0.6 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 5.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.3 | 2.9 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.3 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.9 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.3 | 1.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.9 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 0.3 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.3 | 0.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.3 | 2.9 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.3 | 1.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 2.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.3 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 3.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 2.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 2.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.3 | 0.3 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.3 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 11.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 11.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.3 | 1.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 1.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 1.1 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.3 | 1.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.3 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 3.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 0.3 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.3 | 1.4 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.3 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.3 | 0.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.5 | GO:0006266 | DNA ligation(GO:0006266) DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 1.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 2.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 1.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 2.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.3 | 4.3 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 0.3 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 0.5 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.3 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 1.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 0.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 1.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 8.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.3 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 0.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 0.8 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 2.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 0.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 0.8 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 0.3 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 2.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 3.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 4.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.3 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.3 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 2.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 0.8 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 0.7 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.2 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.2 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.7 | GO:1901213 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901213) |
0.2 | 4.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 2.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 4.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 4.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 1.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 1.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 4.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 3.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.5 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 5.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 1.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 1.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.7 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 0.7 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 1.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.2 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.2 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.2 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.9 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 0.9 | GO:0034397 | telomere localization(GO:0034397) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.9 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 1.3 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 2.9 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 2.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 2.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 2.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 3.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.2 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.2 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.6 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 1.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 3.3 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.4 | GO:0061154 | morphogenesis of an endothelium(GO:0003159) endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 1.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 1.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 1.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 1.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 2.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.4 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 1.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 1.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.4 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 3.1 | GO:0006476 | protein deacetylation(GO:0006476) |
0.2 | 0.2 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.2 | 1.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 10.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.9 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 3.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 5.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 3.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 1.3 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 1.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 1.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 4.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 4.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 1.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 0.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.2 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.2 | 0.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 2.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.4 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.2 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.2 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 0.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 1.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.9 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.5 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.2 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.3 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.8 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.2 | 1.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.2 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.2 | 4.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.3 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.2 | 0.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.9 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 1.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.2 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.2 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.2 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 1.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.6 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.2 | 0.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 1.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 2.9 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 0.2 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.2 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.3 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.2 | 9.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 0.9 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.7 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.3 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.3 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.1 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 4.9 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 3.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 2.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 2.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.7 | GO:0072012 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
0.1 | 0.3 | GO:0016137 | glycoside metabolic process(GO:0016137) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 1.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 1.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 1.9 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.7 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.7 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.7 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 1.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 18.3 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.3 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 1.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.5 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 1.2 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
0.1 | 0.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.3 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.1 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 5.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 2.3 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 1.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.8 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.6 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 1.0 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.4 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 19.5 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 0.6 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0015669 | gas transport(GO:0015669) carbon dioxide transport(GO:0015670) |
0.1 | 2.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.6 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.2 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 2.4 | GO:0019318 | hexose metabolic process(GO:0019318) |
0.1 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 2.6 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 3.2 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 1.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 1.3 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.7 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 8.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.6 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.3 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.7 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 3.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.1 | GO:2000831 | regulation of steroid hormone secretion(GO:2000831) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.8 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.0 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 4.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0007620 | insemination(GO:0007320) copulation(GO:0007620) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.0 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 1.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 1.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.1 | GO:0032438 | melanosome organization(GO:0032438) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.2 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 1.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 1.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 30.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.8 | 8.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.5 | 12.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.2 | 11.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.1 | 6.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.1 | 8.3 | GO:0005642 | annulate lamellae(GO:0005642) |
2.1 | 12.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.0 | 6.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.9 | 5.8 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.9 | 5.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.9 | 5.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.9 | 11.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.8 | 9.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.8 | 10.7 | GO:1990462 | omegasome(GO:1990462) |
1.8 | 5.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.8 | 7.1 | GO:1990130 | Iml1 complex(GO:1990130) |
1.7 | 5.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.7 | 6.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.7 | 5.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.7 | 5.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.6 | 4.9 | GO:0000811 | GINS complex(GO:0000811) |
1.6 | 16.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 4.7 | GO:0031523 | Myb complex(GO:0031523) |
1.6 | 6.2 | GO:0030689 | Noc complex(GO:0030689) |
1.5 | 10.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 3.0 | GO:0042585 | germinal vesicle(GO:0042585) |
1.5 | 6.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.5 | 10.4 | GO:0002102 | podosome(GO:0002102) |
1.5 | 7.3 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 4.4 | GO:0097413 | Lewy body(GO:0097413) |
1.4 | 14.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.4 | 4.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.3 | 5.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.3 | 3.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.3 | 9.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.3 | 2.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.3 | 3.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.3 | 5.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 7.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.2 | 5.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.2 | 8.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.2 | 6.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.2 | 1.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
1.2 | 8.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.2 | 4.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.2 | 15.7 | GO:0031528 | microvillus membrane(GO:0031528) |
1.2 | 2.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.2 | 2.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.2 | 5.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.2 | 8.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.2 | 9.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.2 | 1.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.2 | 3.5 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 9.3 | GO:0001650 | fibrillar center(GO:0001650) |
1.2 | 4.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.2 | 17.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.2 | 6.9 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 1.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.1 | 4.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.1 | 9.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.1 | 3.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.1 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
1.1 | 3.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.1 | 11.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 4.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.1 | 7.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.1 | 44.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.1 | 7.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 2.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.0 | 3.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.0 | 14.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.0 | 3.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 4.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.0 | 33.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.0 | 4.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.0 | 5.8 | GO:0005818 | aster(GO:0005818) |
1.0 | 5.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.9 | 3.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.9 | 6.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.9 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 4.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 8.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.9 | 3.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 2.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 4.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.9 | 8.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.9 | 10.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.9 | 0.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.9 | 13.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.9 | 14.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 9.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 3.6 | GO:0098536 | deuterosome(GO:0098536) |
0.9 | 81.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.9 | 2.6 | GO:1990923 | PET complex(GO:1990923) |
0.9 | 3.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.9 | 2.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.9 | 2.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.9 | 7.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 4.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 3.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.9 | 16.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.9 | 2.6 | GO:0071437 | invadopodium(GO:0071437) |
0.9 | 2.6 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 5.1 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 8.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 3.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 4.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.8 | 37.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.8 | 12.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.8 | 5.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.8 | 1.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.8 | 1.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 4.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.8 | 7.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 46.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.8 | 4.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 1.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 2.3 | GO:0030891 | VCB complex(GO:0030891) |
0.8 | 10.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 33.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.8 | 4.6 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 9.2 | GO:0042581 | specific granule(GO:0042581) |
0.8 | 3.1 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 6.8 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 2.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 25.3 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 11.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 7.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.7 | 2.2 | GO:0055087 | Ski complex(GO:0055087) |
0.7 | 1.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.7 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 12.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 7.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 9.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.7 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.7 | 10.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.7 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 2.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.7 | 3.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 4.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 4.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 7.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.7 | 44.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.7 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 2.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 6.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 6.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.7 | 2.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.7 | 2.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.7 | 7.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.7 | 8.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.7 | 1.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.7 | 0.7 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.7 | 0.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.7 | 3.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.7 | 16.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 5.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 26.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.6 | 6.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 17.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 3.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 19.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 3.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 3.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 1.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 3.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 6.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 6.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.6 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 3.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.6 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 6.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 21.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 9.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.6 | 5.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 3.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 2.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.6 | 9.9 | GO:0005844 | polysome(GO:0005844) |
0.6 | 31.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.6 | 1.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.6 | 2.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 1.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 1.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 1.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 2.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 3.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 3.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.6 | 2.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.6 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 2.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 24.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 2.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 5.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 14.5 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 8.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 1.1 | GO:0016234 | inclusion body(GO:0016234) |
0.5 | 1.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 4.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 33.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.5 | 11.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 1.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 3.1 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 4.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 25.7 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 4.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 6.5 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 6.9 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.5 | 4.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 5.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 4.3 | GO:0097346 | INO80-type complex(GO:0097346) |
0.5 | 2.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 1.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.5 | 1.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 4.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 1.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 4.8 | GO:0030904 | retromer complex(GO:0030904) |
0.5 | 1.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 2.4 | GO:0005819 | spindle(GO:0005819) |
0.5 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 8.2 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.4 | 15.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 0.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 3.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.4 | 3.1 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 3.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 1.8 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 7.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 6.1 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 15.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 8.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 5.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 13.6 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 2.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 5.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.4 | 16.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 13.5 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.4 | 8.8 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 2.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.4 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 13.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.4 | 0.4 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.4 | 3.2 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 1.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 7.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 14.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 4.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 7.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 0.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 1.2 | GO:0005712 | chiasma(GO:0005712) |
0.4 | 1.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 1.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 5.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 9.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 2.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 0.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 3.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 5.0 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 0.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.4 | 1.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 125.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.4 | 105.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 6.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 15.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 13.6 | GO:0005903 | brush border(GO:0005903) |
0.4 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 8.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 19.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 5.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.0 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 1.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 7.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 5.9 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 1.0 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 8.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 19.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 3.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 5.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 2.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 11.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 22.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 2.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 4.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 4.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 4.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 18.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.8 | GO:1990752 | microtubule end(GO:1990752) |
0.3 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 276.1 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.3 | 2.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 0.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.3 | 2.8 | GO:0030496 | midbody(GO:0030496) |
0.3 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 2.5 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 2.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 65.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 10.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 0.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.3 | 15.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 1.5 | GO:0000801 | central element(GO:0000801) |
0.3 | 1.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 2.7 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 1.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 2.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 7.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 2.6 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 8.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 1.9 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 19.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 208.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 5.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 11.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 0.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.8 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 3.3 | GO:0032432 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
0.2 | 2.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.8 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 2.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.2 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.2 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.8 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.1 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 14.6 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 3.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0044448 | cell cortex part(GO:0044448) |
0.1 | 79.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 9.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.6 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 1.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 8.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 138.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 2.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 9.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 5.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.4 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 17.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.0 | GO:0042588 | zymogen granule(GO:0042588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 25.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.5 | 31.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.4 | 13.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.9 | 11.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
3.7 | 11.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
3.2 | 9.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.2 | 12.7 | GO:0009374 | biotin binding(GO:0009374) |
3.1 | 12.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.1 | 12.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.0 | 9.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
3.0 | 9.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.8 | 5.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.8 | 16.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.8 | 19.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.7 | 8.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.7 | 10.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.4 | 7.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.3 | 7.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.3 | 9.3 | GO:0030984 | kininogen binding(GO:0030984) |
2.3 | 9.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.3 | 9.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.3 | 9.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
2.3 | 6.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.3 | 9.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.2 | 11.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.2 | 6.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.2 | 8.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.1 | 4.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.1 | 2.1 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
2.1 | 6.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.1 | 4.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.1 | 10.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.0 | 2.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.0 | 7.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.9 | 3.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.9 | 5.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.9 | 1.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.9 | 1.9 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.8 | 5.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.8 | 5.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.8 | 14.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.8 | 12.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.8 | 1.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.8 | 5.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.7 | 6.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.7 | 1.7 | GO:0002054 | nucleobase binding(GO:0002054) |
1.6 | 9.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.6 | 3.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.6 | 13.0 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.6 | 8.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.6 | 1.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.6 | 9.6 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.6 | 4.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.6 | 7.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.6 | 4.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.6 | 14.0 | GO:0031996 | thioesterase binding(GO:0031996) |
1.5 | 27.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.5 | 4.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.5 | 10.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.5 | 6.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.5 | 1.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.5 | 10.4 | GO:0046790 | virion binding(GO:0046790) |
1.5 | 7.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.5 | 4.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.4 | 31.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.4 | 15.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.4 | 4.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.4 | 4.2 | GO:0035877 | death effector domain binding(GO:0035877) |
1.4 | 9.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.4 | 1.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.4 | 5.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.4 | 5.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 11.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.4 | 12.4 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.4 | 6.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.4 | 16.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
1.4 | 5.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.4 | 4.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.4 | 5.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.3 | 4.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.3 | 5.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.3 | 5.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.3 | 3.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.3 | 17.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.3 | 3.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.2 | 10.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.2 | 9.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.2 | 11.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.2 | 3.7 | GO:0030519 | snoRNP binding(GO:0030519) |
1.2 | 12.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.2 | 7.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.2 | 4.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.2 | 1.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.2 | 3.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.2 | 22.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.2 | 16.1 | GO:0019825 | oxygen binding(GO:0019825) |
1.1 | 4.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.1 | 4.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.1 | 19.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.1 | 22.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.1 | 3.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.1 | 3.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
1.1 | 4.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.1 | 3.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 5.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.1 | 4.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.1 | 33.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.1 | 18.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.1 | 2.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.1 | 6.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.1 | 4.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.1 | 3.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.1 | 3.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 4.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.1 | 16.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.1 | 7.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.1 | 3.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 7.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.1 | 3.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.1 | 4.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.1 | 2.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.0 | 6.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 3.1 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 4.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 2.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.0 | 6.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 1.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
1.0 | 6.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.0 | 3.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.0 | 5.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 3.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.0 | 2.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 1.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.0 | 4.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 3.0 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 4.0 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.0 | 1.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.0 | 3.0 | GO:0048030 | disaccharide binding(GO:0048030) |
1.0 | 11.9 | GO:0005123 | death receptor binding(GO:0005123) |
1.0 | 1.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.0 | 8.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.0 | 2.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 3.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.0 | 3.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.0 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.0 | 14.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.0 | 6.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 9.7 | GO:0004568 | chitinase activity(GO:0004568) |
1.0 | 4.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.0 | 1.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.0 | 12.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.0 | 4.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.0 | 2.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.9 | 14.2 | GO:0005521 | lamin binding(GO:0005521) |
0.9 | 2.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.9 | 2.8 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.9 | 2.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.9 | 8.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.9 | 2.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 10.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.9 | 4.6 | GO:0015288 | porin activity(GO:0015288) |
0.9 | 2.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.9 | 2.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.9 | 7.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.9 | 29.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.9 | 5.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.9 | 2.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 2.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.9 | 10.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.9 | 25.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.9 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.9 | 2.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.9 | 7.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.9 | 9.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.9 | 4.3 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 2.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.9 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 3.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.9 | 1.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.9 | 13.7 | GO:0001848 | complement binding(GO:0001848) |
0.8 | 2.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 3.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 12.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 3.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 3.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.8 | 7.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 4.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.8 | 2.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 2.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.8 | 4.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 5.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 1.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.8 | 1.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 2.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.8 | 4.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.8 | 1.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.8 | 8.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 11.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.8 | 8.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 7.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.8 | 7.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 3.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.8 | 32.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.8 | 3.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.8 | 6.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.8 | 2.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.8 | 3.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 3.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 3.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 1.5 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.7 | 2.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 1.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.7 | 1.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.7 | 2.9 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 8.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.7 | 6.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 5.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.7 | 2.9 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.7 | 10.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 2.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 7.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.7 | 8.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.7 | 2.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 2.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 1.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.7 | 7.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 2.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 1.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 2.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 2.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 3.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 2.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 2.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.7 | 10.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.7 | 2.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.7 | 2.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.7 | 5.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.7 | 2.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 4.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 2.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 3.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 14.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.7 | 11.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 12.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 20.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.7 | 2.0 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 1.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 4.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 2.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.7 | 1.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.7 | 20.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.7 | 3.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 20.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.7 | 4.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 2.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 0.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.7 | 2.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.7 | 2.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.7 | 2.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 2.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 2.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.7 | 19.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.7 | 3.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.7 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 2.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 6.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 1.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 18.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.6 | 6.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 5.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.6 | 7.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.6 | 1.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.6 | 2.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.6 | 1.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.6 | 12.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 4.4 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 1.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 3.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 26.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 18.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 6.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.6 | 4.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 1.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 4.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 1.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 2.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.6 | 1.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.6 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.6 | 1.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.6 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 1.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.6 | 1.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 4.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 4.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.6 | 2.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 1.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 7.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 5.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 1.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 4.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 4.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.6 | 2.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 6.4 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.6 | 2.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 1.7 | GO:0016894 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.6 | 5.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 1.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.6 | 1.7 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.6 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.6 | 4.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 6.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 12.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.6 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.6 | 1.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.6 | 1.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 14.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 4.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 1.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.6 | 1.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 2.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 2.8 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) phosphatidylinositol kinase activity(GO:0052742) |
0.6 | 5.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.6 | 2.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.6 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 2.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 1.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.5 | 3.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 14.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 1.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 4.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 3.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 6.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 5.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 15.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.5 | 27.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.5 | 16.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.5 | 2.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 9.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 9.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 1.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 5.8 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 1.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.5 | 0.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.5 | 5.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 10.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 2.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 2.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 9.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 2.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 3.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 3.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 1.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 1.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 3.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 2.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 4.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 27.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.5 | 47.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.5 | 11.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 3.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 3.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 3.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 2.9 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 24.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.5 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 1.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 5.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 5.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 0.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 4.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.5 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 7.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 1.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 41.0 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.5 | 5.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 3.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 1.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 2.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 11.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 1.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.5 | 2.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 22.7 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.5 | 8.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 30.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 2.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 4.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.4 | 2.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 4.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 2.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 0.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 2.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 6.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 1.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 20.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 2.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 12.2 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 20.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 2.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 1.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 1.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 22.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.4 | 1.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.4 | 8.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 2.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 3.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 2.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 1.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.4 | 0.8 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.4 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 3.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.4 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 3.7 | GO:0070990 | snRNP binding(GO:0070990) |
0.4 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 2.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 1.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.4 | 3.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 4.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 13.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 2.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 5.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 3.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 3.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 1.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 5.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 7.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.4 | 2.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 13.7 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 1.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 1.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 6.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 21.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.4 | 0.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 9.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 3.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 3.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 12.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 0.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 2.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 2.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.4 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 4.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 3.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 1.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 3.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 3.7 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 7.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 39.2 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.3 | 3.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 26.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 1.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 56.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 2.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 3.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 9.6 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.3 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 1.6 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 0.9 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 1.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 1.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 5.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 9.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 4.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 2.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 1.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 2.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 11.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 9.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.3 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 8.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 4.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 1.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 4.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 4.4 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 2.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 0.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 2.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 2.3 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 2.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 5.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 16.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.3 | 5.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 1.9 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.3 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 3.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 47.3 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 3.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 2.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 1.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.0 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 3.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 5.5 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.3 | 9.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 1.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.7 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 2.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 2.7 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 4.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 1.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.5 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 2.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 9.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 4.9 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 12.4 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 1.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 2.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 3.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 32.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 5.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 1.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 2.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 10.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 3.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 5.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 17.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 2.4 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 6.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.3 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.2 | 1.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 3.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 1.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.5 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 9.4 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 1.5 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 0.2 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.2 | 6.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.8 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 1.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 6.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 3.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.5 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 2.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 63.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 3.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 1.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 1.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.5 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 3.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.5 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 4.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 1.8 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 7.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.4 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.6 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 2.3 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 2.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 1.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 5.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 26.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.7 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.0 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 22.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.9 | 1.9 | PID ALK2 PATHWAY | ALK2 signaling events |
1.8 | 46.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.6 | 12.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.4 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.3 | 55.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.3 | 21.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.3 | 10.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.2 | 32.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.2 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.0 | 14.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.0 | 19.0 | PID IGF1 PATHWAY | IGF1 pathway |
1.0 | 30.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.0 | 21.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.0 | 2.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 21.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.9 | 41.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 3.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.9 | 8.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 8.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 3.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 8.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.8 | 1.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.8 | 7.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 1.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 2.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 13.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.8 | 13.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 29.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 4.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 10.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.7 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 3.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 2.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.7 | 10.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 9.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 5.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 15.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 20.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 7.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 19.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 6.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 61.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 12.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 3.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.6 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 31.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 28.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 16.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 3.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.6 | 15.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 7.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 2.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 16.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.6 | 6.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 2.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.6 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 13.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 4.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 9.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 6.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 1.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 14.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 6.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 13.8 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 3.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 5.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 5.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 15.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 3.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 4.9 | PID ATM PATHWAY | ATM pathway |
0.4 | 5.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 7.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 5.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 1.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 2.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 5.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 13.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 10.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 5.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 7.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 11.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 3.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 4.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 1.5 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 1.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 5.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 6.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 5.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 6.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 3.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 7.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 5.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 2.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 8.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 4.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 6.1 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 4.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 4.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 2.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 1.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 2.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 1.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 3.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 4.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 3.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 2.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 2.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
2.3 | 22.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.1 | 21.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.0 | 19.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.8 | 18.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.7 | 10.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.7 | 13.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.6 | 15.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.6 | 4.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 18.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.5 | 7.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.5 | 25.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.5 | 20.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.4 | 15.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.4 | 19.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.3 | 20.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
1.3 | 1.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.3 | 14.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.3 | 14.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.2 | 8.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.2 | 3.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.2 | 32.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.2 | 12.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.2 | 17.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 12.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.1 | 12.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 18.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.1 | 8.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.1 | 8.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 2.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.0 | 1.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.0 | 12.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 7.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 16.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.0 | 2.9 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.0 | 8.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 13.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.0 | 9.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.0 | 36.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.0 | 14.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 16.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.0 | 16.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.9 | 2.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 14.5 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.9 | 13.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 0.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 1.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.9 | 4.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.9 | 8.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.9 | 23.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.8 | 18.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 14.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 9.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 70.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.8 | 9.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.8 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 7.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.8 | 13.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.8 | 15.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 16.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.7 | 9.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 6.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 15.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.7 | 7.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 2.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.7 | 1.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.7 | 5.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 6.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 8.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.7 | 12.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 12.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.7 | 13.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 5.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 13.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 14.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 4.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.6 | 13.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.6 | 1.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 5.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 17.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 7.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 9.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 8.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 3.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 16.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 8.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.6 | 8.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.6 | 12.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 5.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 12.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 16.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.5 | 5.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 15.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 3.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 11.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 4.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 10.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 6.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 3.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 3.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.5 | 4.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 9.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 8.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 18.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.5 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 19.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 23.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 3.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 57.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 1.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 63.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 10.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.4 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 13.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 10.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 6.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 8.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.4 | 3.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 10.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 7.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 4.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 17.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 1.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 6.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 8.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 4.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 12.5 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.4 | 7.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 29.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 4.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 2.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 8.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 10.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 4.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 11.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 6.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.4 | 11.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 1.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 2.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 18.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 2.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 0.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 0.6 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 2.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 11.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 2.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 0.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 3.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 0.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 1.6 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 16.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 3.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.3 | 1.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 1.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 6.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 7.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 2.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 4.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 6.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 4.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 22.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 0.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 6.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 5.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 4.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.6 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.3 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 2.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |